Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00450944
Status:
COMPLETED
Last Update Posted:
2021-04-14
First Post:
2007-03-20
Brief Title:
Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia
Sponsor:
Albert Einstein College of Medicine
Organization:
Albert Einstein College of Medicine